Divi's Laboratories Limited (DIVISLAB) — Announcement | 1 August 2026(2 announcements)

· NSE Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
1 Announcement Neutral 📄 PDF
📢 Key Event
Audio recording of Q1 FY27 earnings call made publicly available
💡 Investor Takeaway
Shareholders can now review the full audio of management's discussion on quarterly results and future expectations.

Divi's Laboratories announced that the audio recording of its Q1 FY27 earnings conference call held on August 1, 2026, is now available on its investor relations website, providing shareholders access to management commentary on performance and outlook.

2 Announcement Neutral 📄 PDF
📢 Key Event
Board approves Q1 FY2026 financial results and senior management appointments
🔄 What Changed
Consolidated revenue grew 26% YoY to ₹3,144 crores; PAT grew 66% YoY to ₹902 crores
💡 Investor Takeaway
The company delivered strong YoY growth in revenue and profit, indicating robust quarterly performance.

Divi's Laboratories announced its August 1, 2026 board meeting outcomes, approving unaudited standalone and consolidated financial results for Q1 FY2026 ending June 30, 2026, along with senior management appointments. The consolidated statement shows total income of ₹3,144 crores, up from ₹2,529 crores YoY, with profit before tax at ₹1,180 crores versus ₹733 crores previously, and profit after tax at ₹902 crores compared to ₹545 crores. Standalone figures report total income of ₹3,037 crores and PAT of ₹891 crores. The press release highlights 26% YoY growth in consolidated revenue and 66% YoY growth in PAT, reflecting strong operational performance.

About Divi's Laboratories Limited (DIVISLAB)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹1,79,470.03 Cr P/E: 72.4 ROE: 16.6% ROCE: 22.1%

View full DIVISLAB stock details →

📡 Get AI alerts when DIVISLAB files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track DIVISLAB — Free

📊 More DIVISLAB filings

See all DIVISLAB filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when DIVISLAB files new disclosures

Track DIVISLAB filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track DIVISLAB — Free

Free account · 2 AI queries/day